Kennen MacKay

Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases

Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases

7 days ago   |   Xconomy

One of the risks to a newborn's life comes from the mother's immune system. It attacks the platelets of the fetus, depleting these blood-clotting cells and risking...
Read more ...

Biotech Briefing: Aristea and Ionis CEOs Make Predictions for Biotech in 2020

5 monthes ago   |   San Diego Biotechnology

Reports + Research Aristea and Ionis CEOs Make Predictions for Biotech in 2020 Life Science Leader talks with Drs. Stanley Crooke and James Mackay about what the next decade...
Read more ...

ESMO 2019: PARP and Prostate, SeaGen's Win, KRAS Update & More

ESMO 2019: PARP and Prostate, SeaGen's Win, KRAS Update & More

7 monthes ago   |   Xconomy

The European Society for Medical Oncology meeting has wrapped up in Barcelona, the last major clinical cancer conference until December's annual ASH meeting for blood diseases...
Read more ...

FDA Doesn't Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb

FDA Doesn't Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb

8 monthes ago   |   Xconomy

Peanut allergy sufferers know they need to stay away from certain foods that can put them in danger. But what about accidental exposure? Even trace amounts of peanut protein in...
Read more ...

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

8 monthes ago   |   Xconomy   |   2 articles

The treatment landscape for lung cancer has shifted significantly over the past few years , and more changes could be on the way. At the World Conference on Lung Cancer in...
Read more ...

Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet

Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet

8 monthes ago   |   Xconomy

Three patents that extend the exclusivity of Alexion Pharmaceuticals' franchise rare disease drug will now face a patent challenge from Amgen. On Friday, a court within the US...
Read more ...

A Novel Prediction Model for Bloodstream Infections in Hepatobiliary-Pancreatic Surgery Patients

One year ago   |   Springer

Abstract Background Bloodstream infections are an important source of postoperative mortality in hepatobiliary-pancreatic surgery patients, and no prediction model has been...
Read more ...

Aristea Therapeutics Raises $15M to Develop Anti-Inflammatory Drugs

Aristea Therapeutics Raises $15M to Develop Anti-Inflammatory Drugs

One year ago   |   Xconomy   |   2 articles

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca...
Read more ...

Novo helps birth startup advancing an AstraZeneca castoff with $15M; Japan's Fuji Pharma wagers $50M on Alvotech's biosimilars

One year ago   |   San Diego Biotechnology

? With backing from Novo Holdings and a drug from AstraZeneca, Aristea Therapeutics is unveiling a $15 million Series A that will kickstart Phase II studies of its lead...
Read more ...

Connect Taps Tega Therapeutics CEO, Springboard Grad as Chairman

Connect Taps Tega Therapeutics CEO, Springboard Grad as Chairman

One year ago   |   Xconomy

Connect, the longstanding nonprofit organization that runs one of San Diego's best-known startup accelerator programs, said Thursday that Tega Therapeutics CEO Tim Scott will...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create... Read more ...

How a protein can inhibit cancer development in mice

In a new study, researchers have discovered how the protein PP2A can inhibit tumor growth in mice. The protein turns off an enzyme that stimulates cell growth, thus inhibiting... Read more ...

Biotechnology: Metal collector made of bacteria

Bacteria, fungi and plants sometimes produce metal-binding substances that can be harnessed, for example for the extraction of raw materials, for their separation, for cleaning... Read more ...

Rejuvenated fibroblasts can recover the ability to contract

A recent study has shown that rejuvenated fibroblasts can recover their ability to self-contract. This encouraging discovery holds great potential for applications in... Read more ...

Directed protein evolution with CRISPR-Cas9

New area of application for gene scissors: Optimized proteins for biomedical research. Read more ...